| Literature DB >> 31208189 |
Gang Zhang1, Tian Xia1, Jinbiao Zhao1, Ling Liu1, Pingli He1, Shuai Zhang1, Liying Zhang1.
Abstract
OBJECTIVE: Two experiments were conducted to evaluate tetrabasic zinc chloride (TBZC) on the health of weaned pigs, and to determine the optimal supplemental concentrations and whether dietary TBZC could replace the pharmacological concentrations of dietary zinc oxide (ZnO) to improve growth performance and decrease Zn excretion in weaned pigs.Entities:
Keywords: Growth Performance; Tetrabasic Zinc Chloride; Weaned Pigs; Zinc Excretion
Year: 2019 PMID: 31208189 PMCID: PMC6946966 DOI: 10.5713/ajas.18.0914
Source DB: PubMed Journal: Asian-Australas J Anim Sci ISSN: 1011-2367 Impact factor: 2.509
Ingredients and chemical compositions of the basal diets used in Exp. 1 and 2 (as-fed basis)
| Items | Exp. 1 | Exp. 2 | ||
|---|---|---|---|---|
|
|
| |||
| d 0 to 14 | d 14 to 28 | d 0 to 14 | d 14 to 28 | |
| Ingredient (%) | ||||
| Corn | 60.58 | 66.16 | 51.64 | 58.53 |
| Soybean meal (44% CP) | 10.00 | 17.00 | 16.85 | 13.40 |
| Extruded soybean | - | - | 14.20 | 11.00 |
| Soy protein concentrate | 9.00 | 5.60 | - | - |
| Fish meal | 4.70 | 2.00 | 4.00 | 5.00 |
| Whey power | 10.00 | 4.00 | 8.00 | 7.00 |
| Soybean oil | 1.26 | 1.00 | 1.65 | 1.32 |
| Dicalcium phosphate | 0.79 | 0.86 | 1.21 | 1.10 |
| Sodium bicarbonate | 0.88 | 0.85 | - | - |
| Limestone | 0.74 | 0.73 | 0.74 | 0.50 |
| Salt | 0.30 | 0.30 | 0.30 | 0.50 |
| L-Lys HCl | 0.60 | 0.50 | 0.46 | 0.40 |
| L-Thr | 0.22 | 0.17 | 0.13 | 0.10 |
| DL-Met | 0.23 | 0.17 | 0.12 | 0.15 |
| Chromic oxide | - | - | - | 0.30 |
| Choline chloride (40% Choline) | 0.20 | 0.16 | 0.20 | 0.20 |
| Vitamin-mineral premix | 0.50 | 0.50 | 0.50 | 0.50 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Calculated composition (%) | ||||
| Digestible energy (kcal/kg) | 3,542 | 3,480 | 3,550 | 3,480 |
| Crude protein | 20.50 | 19.00 | 20.50 | 18.90 |
| Ca | 0.84 | 0.74 | 0.85 | 0.75 |
| P | 0.67 | 0.64 | 0.66 | 0.65 |
| Available P | 0.47 | 0.44 | 0.46 | 0.44 |
| Standardized ileal digestible amino acid (%) | ||||
| Lys | 1.42 | 1.30 | 1.41 | 1.30 |
| Met | 0.41 | 0.40 | 0.41 | 0.40 |
| Thr | 0.82 | 0.75 | 0.80 | 0.74 |
| Trp | 0.22 | 0.21 | 0.22 | 0.21 |
Vitamin and mineral premix provided the following per kilogram of diet: 12,000 IU vitamin A (vitamin A acetate), 2,500 IU vitamin D (vitamin D3), 30 IU vitamin E (dl-α-tocopheryl acetate), 12 μg vitamin B12, 3 mg vitamin K (menadione sodium bisulfate), 15 mg d-pantothenic acid (calcium pantothenate), 40 mg nicotinic acid, 30 mg Mn (manganese oxide), 120 mg Fe (ferrus sulfate), 150 mg Cu (copper sulfate), 0.35 mg I (ethylenediamine dihydroiodide), and 0.3 mg Se (sodium selenite). In addition, vitamin and mineral premix used in Exp. 1 contained 125 mg Zn (zinc sulfate), and the premix in Exp. 2 did not.
Analyzed mineral compositions of diets used in Exp. 1
| Items | TBZC (mg/kg Zn) | ||||
|---|---|---|---|---|---|
|
| |||||
| 0 | 1,200 | 1,800 | 2,400 | 3,000 | |
| Phase 1, d 0 to 14 | |||||
| Zn (mg/kg) | 142 | 1,340 | 1,942 | 2,539 | 3,144 |
| Cu (mg/kg) | 163 | 161 | 164 | 159 | 161 |
| Fe (mg/kg) | 312 | 323 | 318 | 318 | 319 |
| Phase 2, d 14 to 28 | |||||
| Zn (mg/kg) | 144 | 1,346 | 1,947 | 2,546 | 3,143 |
| Cu (mg/kg) | 159 | 160 | 158 | 160 | 159 |
| Fe (mg/kg) | 322 | 327 | 330 | 323 | 325 |
Analysis conducted in duplicates, and the Zn concentration in the basal diet (no TBZC supplementation) was 125 mg/kg as zinc sulfate (ZnSO4).
TBZC, tetrabasic zinc chloride; Zn, zinc; Cu, copper; Fe, iron.
Analyzed mineral compositions of diets used in Exp. 2
| Items | TBZC (mg/kg Zn) | ZnO (mg/kg Zn) | |||
|---|---|---|---|---|---|
|
|
| ||||
| 0 (NC) | 1,000 | 1,250 | 1,500 | 2,250 | |
| Phase 1, d 0 to 14 | |||||
| Zn (mg/kg) | 33 | 1,045 | 1,272 | 1,568 | 2,259 |
| Cu (mg/kg) | 177 | 179 | 173 | 171 | 175 |
| Fe (mg/kg) | 288 | 293 | 290 | 281 | 280 |
| Phase 2, d 14 to 28 | |||||
| Zn (mg/kg) | 29 | 1,072 | 1,315 | 1,580 | 2,149 |
| Cu (mg/kg) | 175 | 177 | 172 | 174 | 172 |
| Fe (mg/kg) | 298 | 294 | 295 | 285 | 277 |
Analysis conducted in duplicates.
TBZC, tetrabasic zinc chloride; NC, negative control without Zn source supplementation; ZnO, positive control, NC+2,250 mg/kg Zn as Zn oxide (ZnO); Zn, zinc; Cu, copper; Fe, iron.
Effects of dietary tetrabasic zinc chloride supplementation on growth performance and diarrhea incidence of weaned pigs in Exp. 1
| Items | TBZC (mg/kg Zn) | SEM | p-value | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
| ||||||||
| 0 | 1,200 | 1,800 | 2,400 | 3,000 | Treatment | Linear | Quadratic | ||
| Phase 1, d 0 to 14 | |||||||||
| ADG (g) | 331 | 368 | 367 | 364 | 366 | 11.56 | 0.02 | 0.07 | 0.09 |
| ADFI (g) | 527 | 560 | 546 | 559 | 555 | 13.33 | 0.16 | 0.06 | 0.23 |
| G:F | 0.63 | 0.66 | 0.67 | 0.65 | 0.66 | 0.01 | <0.01 | <0.01 | <0.01 |
| Diarrhea incidence (%) | 10.95 | 0.48 | 0.71 | 1.67 | 0.95 | 0.94 | <0.01 | <0.01 | <0.01 |
| Phase 2, d 14 to 28 | |||||||||
| ADG (g) | 387 | 417 | 438 | 426 | 375 | 15.24 | <0.01 | 0.89 | <0.01 |
| ADFI (g) | 654 | 689 | 691 | 690 | 659 | 15.54 | 0.28 | 0.58 | 0.04 |
| G:F | 0.59 | 0.61 | 0.63 | 0.62 | 0.57 | 0.01 | <0.01 | 0.41 | <0.01 |
| Diarrhea incidence (%) | 6.91 | 0.71 | 0.24 | 0.48 | 0.95 | 0.76 | <0.01 | <0.01 | <0.01 |
| Overall, d 0 to 28 | |||||||||
| ADG (g) | 359 | 393 | 403 | 395 | 370 | 12.10 | <0.01 | 0.04 | <0.01 |
| ADFI (g) | 591 | 625 | 618 | 625 | 606 | 13.47 | 0.08 | 0.17 | 0.02 |
| G:F | 0.61 | 0.63 | 0.65 | 0.63 | 0.61 | 0.01 | 0.04 | 0.37 | <0.01 |
| Diarrhea incidence (%) | 8.93 | 0.60 | 0.48 | 1.07 | 0.95 | 0.63 | <0.01 | 0.03 | <0.01 |
Values are least square means (n = 6 per treatment), and zinc (Zn) concentration in the basal diet (no TBZC supplementation) was 125 mg/kg as zinc sulfate (ZnSO4).
TBZC, tetrabasic zinc chloride; SEM, standard error of the mean; ADG, average daily gain; ADFI, average daily feed intake; G:F, feed efficiency.
Linear and quadratic effects of increasing TBZC concentrations (0 to 3,000 mg/kg Zn).
Least square means within a row with different superscripts differ (p<0.05).
Effects of dietary tetrabasic zinc chloride supplementation on hematological parameters in weaned pigs in Exp. 1
| Items | TBZC (g/kg Zn) | SEM | p-value | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
| ||||||||
| 0 | 1,200 | 1,800 | 2,400 | 3,000 | Treatment | Linear | Quadratic | ||
| White blood cell (×109/L) | 25.70 | 25.42 | 21.98 | 24.40 | 26.23 | 1.86 | 0.53 | 0.90 | 0.24 |
| Red blood cell (×1012/L) | 6.48 | 6.34 | 6.49 | 6.80 | 7.09 | 0.13 | <0.01 | <0.01 | 0.02 |
| Hemoglobin (g/L) | 98.19 | 105.40 | 102.25 | 113.60 | 114.40 | 4.25 | 0.06 | <0.01 | 0.65 |
| Hematocrit (%) | 34.01 | 35.98 | 36.33 | 38.22 | 38.70 | 1.32 | 0.14 | 0.01 | 0.92 |
| Platelet count (×109/L) | 206.75 | 228.80 | 201.50 | 228.00 | 221.00 | 14.55 | 0.58 | 0.51 | 0.86 |
Values are least square means (n = 6 per treatment), and zinc (Zn) concentration in the basal diet (no TBZC supplementation) was 125 mg/kg as zinc sulfate (ZnSO4).
TBZC, tetrabasic zinc chloride; SEM, standard error of the mean.
Linear and quadratic effects of increasing TBZC concentrations (0 to 3,000 mg/kg Zn).
Least square means within a row with different superscripts differ (p<0.05).
Effects of dietary tetrabasic zinc chloride supplementation on serum biochemical and liver antioxidant parameters in weaned pigs in Exp. 1
| Items | TBZC (mg/kg Zn) | SEM | p-value | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
| ||||||||
| 0 | 1,200 | 1,800 | 2,400 | 3,000 | Treatment | Linear | Quadratic | ||
| Serum biochemical parameters | |||||||||
| AST (U/L) | 67.60 | 64.30 | 53.90 | 80.63 | 80.75 | 4.67 | <0.01 | 0.03 | <0.01 |
| ALT (U/L) | 60.11 | 71.20 | 81.88 | 94.55 | 91.37 | 6.30 | 0.02 | <0.01 | 0.26 |
| ALP (U/L) | 376.6 | 467.3 | 556.9 | 764.4 | 682.6 | 83.37 | 0.03 | <0.01 | 0.99 |
| TP (g/L) | 60.01 | 63.42 | 65.26 | 62.50 | 57.56 | 1.73 | 0.19 | 0.47 | 0.04 |
| Liver antioxidant parameters | |||||||||
| MDA (nmol/mg) | 0.33 | 0.34 | 0.30 | 0.30 | 0.38 | 0.01 | <0.01 | 0.06 | <0.01 |
| GSH-Px (U/mg) | 41.86 | 42.27 | 57.87 | 48.38 | 25.00 | 2.26 | <0.01 | 0.02 | <0.01 |
| T-AOC (U/mg) | 0.64 | 0.56 | 0.76 | 0.75 | 0.46 | 0.03 | <0.01 | 0.13 | <0.01 |
| SOD (U/mg) | 4.23 | 4.03 | 5.06 | 4.43 | 3.94 | 0.34 | 0.20 | 0.96 | 0.19 |
Values are least square means (n = 6 per treatment), and zinc (Zn) concentration in the basal diet (no TBZC supplementation) was 125 mg/kg as zinc sulfate (ZnSO4).
TBZC, tetrabasic zinc chloride; SEM, standard error of the mean; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; TP, total protein; MDA, malondialdehyde; GSH-Px, glutathione peroxidase; T-AOC, total antioxidant capacity; SOD, superoxide dismutase.
Linear and quadratic effects of increasing TBZC concentrations (0 to 3,000 mg/kg Zn).
Least square means within a row with different superscripts differ (p<0.05).
Effects of dietary tetrabasic zinc chloride supplementation on organ weight and visceral index in weaned pigs in Exp. 1
| Items | TBZC (mg/kg Zn) | SEM | p-value | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
| ||||||||
| 0 | 1,200 | 1,800 | 2,400 | 3,000 | Treatment | Linear | Quadratic | ||
| Weight (g) | |||||||||
| Heart | 104.40 | 100.79 | 101.84 | 90.85 | 98.44 | 5.84 | 0.56 | 0.25 | 0.85 |
| Liver | 465.59 | 473.00 | 475.69 | 498.17 | 532.45 | 15.90 | 0.07 | 0.01 | 0.14 |
| Spleen | 46.80 | 45.69 | 47.16 | 41.80 | 49.98 | 3.67 | 0.64 | 0.89 | 0.47 |
| Lung | 225.33 | 230.99 | 286.27 | 252.19 | 219.98 | 12.25 | 0.01 | 0.56 | 0.01 |
| Kidney | 94.56 | 97.98 | 102.47 | 106.43 | 121.60 | 3.77 | <0.01 | <0.01 | 0.05 |
| Visceral index (g/kg) | |||||||||
| Heart | 5.58 | 5.50 | 5.68 | 5.14 | 5.31 | 0.29 | 0.69 | 0.37 | 0.72 |
| Liver | 25.91 | 26.00 | 26.86 | 27.72 | 29.29 | 0.85 | 0.08 | 0.01 | 0.18 |
| Spleen | 2.40 | 2.50 | 2.66 | 2.38 | 2.73 | 0.18 | 0.60 | 0.35 | 0.93 |
| Lung | 12.25 | 13.25 | 15.47 | 12.85 | 11.82 | 0.70 | 0.03 | 0.89 | <0.01 |
| Kidney | 5.05 | 5.24 | 5.77 | 5.97 | 6.56 | 0.15 | <0.01 | <0.01 | 0.06 |
Values are least square means (n = 6 per treatment), and zinc (Zn) concentration in the basal diet (no TBZC supplementation) was 125 mg/kg as ZnSO4.
TBZC, tetrabasic zinc chloride; SEM, standard error of the mean.
Linear and quadratic effects of increasing TBZC concentrations (0 to 3,000 mg/kg Zn).
Least square means within a row with different superscripts differ (p<0.05).
Effects of dietary tetrabasic zinc chloride supplementation on organ Zn concentrations in weaned pigs in Exp. 1
| Items | TBZC (mg/kg Zn) | SEM | p-value | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
| ||||||||
| 0 | 1,200 | 1,800 | 2,400 | 3,000 | Treatment | Linear | Quadratic | ||
| Heart (mg/kg) | 24.27 | 56.90 | 92.22 | 149.16 | 199.85 | 23.20 | <0.01 | <0.01 | 0.14 |
| Liver (mg/kg) | 106.60 | 245.29 | 644.28 | 736.66 | 987.32 | 43.96 | <0.01 | <0.01 | 0.03 |
| Kindey (mg/kg) | 22.64 | 26.85 | 49.44 | 135.02 | 240.40 | 8.00 | <0.01 | <0.01 | 0.12 |
| Pancreas (mg/kg) | 43.43 | 91.92 | 469.60 | 363.74 | 937.69 | 96.97 | <0.01 | <0.01 | 0.02 |
Values are least square means (n = 6 per treatment), and zinc (Zn) concentration in the basal diet (no TBZC supplementation) was 125 mg/kg as ZnSO4.
TBZC, tetrabasic zinc chloride; SEM, standard error of the mean.
Linear and quadratic effects of increasing TBZC concentrations (0 to 3,000 mg/kg Zn).
Least square means within a row with different superscripts differ (p<0.05).
Figure 1Effects of different concentrations (0 to 3,000 mg/kg zinc) of dietary tetrabasic zinc chloride (TBZC) supplementation on tissue structure of heart, liver, spleen, lung and kidney in weaned pigs. A–E represent tissues of heart, liver, spleen, lung and kidney, and 1–5 represent dietary TBZC supplemental concentrations of 0, 1,200, 1,800, 2,400, and 3,000 mg/kg zinc (Zn), respectively. Heart tissue with 3,000 mg/kg Zn as TBZC (A5) showed interstitial edema (black arrows); liver tissue with 3,000 mg/kg Zn as TBZC (B5) showed stem cell swelling (green arrow), hepatic sinus dilatation (yellow arrow) and lymph cell infiltration (black arrow); lung tissue with 2,400 and 3,000 mg/kg Zn as TBZC (D4 and D5, respectively) exhibited alveolar collapse and compensatory expansion of the alveolar spaces (yellow arrows), thickened alveolar wall (green arrows), and proteinaceous mucus in the alveolar space (blue arrows and black arrow); kidney tissue with 3,000 mg/kg Zn as TBZC (E5) exhibited glomerular lobes (yellow arrow), atrophy (black arrow), and tubulointerstitial hyperemia (blue arrow). H&E, ×200.
Effects of dietary tetrabasic zinc chloride supplementation on growth performance and diarrhea incidence of weaned pigs in Exp. 2
| Items | TBZC (mg/kg Zn) | ZnO (mg/kg Zn) | SEM | p-value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| NC vs ZnO | TBZC vs ZnO | TBZC | ||||||||
|
|
|
| ||||||||
| 0 (NC) | 1,000 | 1,250 | 1,500 | 2,250 | Linear | Quadratic | ||||
| Phase 1, d 0 to 14 | ||||||||||
| ADG (g) | 326 | 356 | 378 | 370 | 356 | 8.28 | 0.02 | 0.04 | <0.01 | 0.72 |
| ADFI (g) | 513 | 548 | 557 | 551 | 553 | 13.82 | 0.03 | 0.89 | 0.14 | 0.54 |
| G:F | 0.63 | 0.65 | 0.68 | 0.67 | 0.64 | 0.01 | 0.28 | 0.02 | <0.01 | 0.57 |
| Diarrhea incidence (%) | 17.76 | 7.47 | 4.78 | 3.75 | 5.06 | 0.88 | <0.01 | 0.78 | <0.01 | <0.01 |
| Phase 2, d 14 to 28 | ||||||||||
| ADG (g) | 469 | 517 | 529 | 540 | 502 | 12.66 | 0.08 | 0.02 | <0.01 | 0.98 |
| ADFI (g) | 883 | 922 | 907 | 929 | 892 | 22.78 | 0.74 | 0.16 | 0.22 | 0.90 |
| G:F | 0.53 | 0.56 | 0.58 | 0.58 | 0.56 | 0.01 | 0.04 | 0.07 | <0.01 | 0.96 |
| Diarrhea incidence (%) | 9.59 | 3.75 | 2.73 | 2.53 | 3.60 | 0.56 | <0.01 | 0.43 | <0.01 | 0.06 |
| Overall, d 0 to 28 | ||||||||||
| ADG (g) | 397 | 437 | 454 | 455 | 429 | 8.41 | 0.02 | 0.01 | <0.01 | 0.84 |
| ADFI (g) | 698 | 735 | 732 | 740 | 723 | 15.19 | 0.19 | 0.33 | 0.07 | 0.71 |
| G:F | 0.58 | 0.60 | 0.63 | 0.62 | 0.60 | 0.01 | 0.07 | 0.02 | <0.01 | 0.68 |
| Diarrhea incidence (%) | 13.67 | 5.61 | 3.76 | 3.14 | 4.33 | 0.53 | <0.01 | 0.73 | <0.01 | <0.01 |
Values are least square means (n = 8 per treatment).
TBZC, tetrabasic zinc chloride; NC, negative control without zinc (Zn) source supplementation; ZnO, positive control, NC+2,250 mg/kg Zn as Zn oxide (ZnO); SEM, standard error of the mean; ADG, average daily gain; ADFI, average daily feed intake; G:F, feed efficiency.
Comparisons between the NC diet vs the ZnO diet, and the ZnO diet vs mean of TBZC treatments (1,000 to 1,500 mg/kg Zn) using contrast. Linear and quadratic effects of increasing TBZC concentrations (0 to 1,500 mg/kg Zn).
Effects of dietary tetrabasic zinc chloride supplementation on mineral absorption and excretion in weaned pigs in Exp. 2
| Items | TBZC (mg/kg Zn) | TBZC1000 vs ZnO | SEM | p-value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||
| ZnO (mg/kg Zn) | TBZC1250 vs ZnO | TBZC1500 vs ZnO | TBZC | ||||||||
|
|
|
| |||||||||
| 0 (NC) | 1,000 | 1,250 | 1,500 | 2,250 | Linear | Quadratic | |||||
| ADFI (d 26 to 28; as-fed basis, g) | 955 | 994 | 984 | 1,001 | 971 | 43.96 | 0.71 | 0.85 | 0.67 | 0.17 | 0.79 |
| Zn | |||||||||||
| Intake (mg/d) | 28 | 1,066 | 1,295 | 1,581 | 2,087 | 67.00 | <0.01 | <0.01 | 0.02 | <0.01 | 0.49 |
| Fecal (mg/d) | 44 | 897 | 941 | 1,618 | 1,788 | 61.45 | <0.01 | <0.01 | 0.17 | <0.01 | <0.01 |
| Absorption (%) | −58.46 | 15.86 | 27.17 | −2.74 | 14.29 | 6.87 | 0.64 | <0.01 | <0.01 | 0.08 | <0.01 |
| Cu | |||||||||||
| Intake (mg/d) | 168 | 185 | 169 | 181 | 167 | 7.79 | 0.11 | 0.87 | 0.28 | 0.46 | 0.69 |
| Fecal (mg/d) | 147 | 157 | 132 | 158 | 152 | 7.05 | 0.66 | 0.07 | 0.59 | 0.62 | 0.41 |
| Absorption (%) | 12.41 | 15.15 | 21.91 | 12.09 | 8.73 | 1.55 | 0.02 | <0.01 | 0.11 | 0.10 | 0.01 |
| Fe | |||||||||||
| Intake (mg/d) | 285 | 292 | 290 | 285 | 269 | 12.70 | 0.21 | 0.29 | 0.43 | 0.31 | 0.93 |
| Fecal (mg/d) | 281 | 290 | 262 | 286 | 279 | 13.44 | 0.58 | 0.03 | 0.72 | 0.11 | 0.39 |
| Absorption (%) | 1.36 | 0.47 | 9.71 | −0.67 | −3.16 | 2.34 | 0.34 | <0.01 | 0.44 | 0.57 | 0.06 |
Values are least square means (n = 8 per treatment).
TBZC, tetrabasic zinc chloride; NC, negative control without zinc (Zn) source supplementation; ZnO, positive control, NC+2,250 mg/kg Zn as Zn oxide (ZnO); SEM, standard error of the mean; ADFI, average daily feed intake; Cu, copper; Fe, iron.
Comparisons between the TBZC1000 diet vs the ZnO diet, the TBZC1250 diet vs the ZnO diet, and the TBZC1500 diet vs the ZnO diet using contrast. Linear and quadratic effects of increasing TBZC concentrations (0 to 1,500 mg/kg Zn).